Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | STAT6 | P42226 | 1/20 | 0.54 |
| ▸ | ASAH1 | Q13510 | 6/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.51 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11443588 | 0.84 | KMT2A (0.60) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL250172 | 0.84 | HTT (0.66) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL857765 | 0.82 | SMN1; SMN2 (0.61) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL5348211 | 0.82 | SMN1; SMN2 (0.54) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL8818598 | 0.82 | KMT2A (0.54) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL1735988 | 0.81 | ASAH1 (0.55) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL29585279 | 0.81 | SMN1; SMN2 (0.54) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL28377896 | 0.81 | SMN1; SMN2 (0.54) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL11882632 | 0.81 | KMT2A (0.57) | SMN1; SMN2KMT2AMEN1LMNASTAT6 | |
| SCHEMBL5133119 | 0.81 | KMT2A (0.57) | SMN1; SMN2KMT2AMEN1LMNASTAT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4211839-A | SILVER HALIDE AND ORGANIC SILVER SALT PREPARED IN AN IMINO COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1980-07-08 | — | — | US | claimed |
| US-12479842-B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | UNIVERSITE DE MONTREAL (CA) | 2025-11-25 | — | — | US | disclosed |
| US-20250270207-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | UNIVERSITE DE MONTREAL (CA) | 2025-08-28 | — | — | US | disclosed |
| US-12139488-B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | Université de Montréal (CA) | 2024-11-12 | — | — | US | disclosed |
| US-20240317747-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | Université de Montréal (CA) | 2024-09-26 | — | — | US | disclosed |
| US-12060353-B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | Université de Montréal (CA) | 2024-08-13 | — | — | US | disclosed |
| US-20240217971-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | Université de Montréal (CA) | 2024-07-04 | — | — | US | disclosed |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-30 | — | — | US | disclosed |
| US-20240140945-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | Université de Montréal (CA) | 2024-05-02 | — | — | US | disclosed |
| EP-4347544-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | Dow Technology Investments LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-0063017-A1 | Detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-10-20 | — | — | EP | disclosed |
| EP-0062523-A2 | Detergent additive compositions and preparations and use thereof in detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-10-13 | — | — | EP | disclosed |
| EP-0057088-A1 | Detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-08-04 | — | — | EP | disclosed |
| EP-0051987-A1 | Bleach activator compositions, preparation thereof and use in granular detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1982-05-19 | — | — | EP | disclosed |
| US-4321157-A | SILICA OR SILICATE, ORGANIC PEROXY ACID BLEACH PRECURSOR, ALIPHATIC ALCOHOL-ALKYLENE OXIDE CONDENSATE NONIONIC SURFACTANT | THE PROCTER & GAMBLE COMPANY (US) | 1982-03-23 | — | — | US | disclosed |
| EP-0034387-A2 | Mulls containing chain structure clay suspension aids | THE PROCTER & GAMBLE COMPANY (US) | 1981-08-26 | — | — | EP | disclosed |
| EP-0028432-A1 | Granular laundry compositions | THE PROCTER & GAMBLE COMPANY (US) | 1981-05-13 | — | — | EP | disclosed |
| US-4264466-A | LAUNDRY DETERGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1981-04-28 | — | — | US | disclosed |
| US-4248928-A | TETRAACETYL AKYLENEDIAMINES OR TETRAACETYL GLYCOURIL PEROXY BLEACH PRECURSOR | THE PROCTER & GAMBLE COMPANY (US) | 1981-02-03 | — | — | US | disclosed |
| US-4179390-A | Laundry additive product | THE PROCTER & GAMBLE COMPANY (US) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270207-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | BRAF, NRAS, KRAS | SMN1; SMN2 3085/4885KMT2A 2292/4885MEN1 1789/4885 |
| US-20240140945-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | BRAF, NRAS, KRAS | SMN1; SMN2 3085/4885KMT2A 2292/4885MEN1 1789/4885 |
| US-20240317747-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | BRAF, NRAS, KRAS | SMN1; SMN2 3085/4885KMT2A 2292/4885MEN1 1789/4885 |
| US-12139488-B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | BRAF, NRAS, KRAS | SMN1; SMN2 3085/4885KMT2A 2292/4885MEN1 1789/4885 |
| US-12060353-B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | BRAF, NRAS, KRAS | SMN1; SMN2 3085/4885KMT2A 2292/4885MEN1 1789/4885 |
| US-12479842-B2 | Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease | BRAF, NRAS, DPYD | SMN1; SMN2 3097/4885KMT2A 2305/4885MEN1 1888/4885 |
| US-20240217971-A1 | PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE | BRAF, NRAS, DPYD | SMN1; SMN2 3097/4885KMT2A 2305/4885MEN1 1888/4885 |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | ADH1C, ADH5, ALDH2 | SMN1; SMN2 1192/4885KMT2A 191/4885MEN1 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.